The author discusses current expectations in bioprocessing and lays a framework for using NMR to enhance a QbD approach.
F.C. Girard
Advertisement
F.C. Girard, PhD, is CEO of Spinnovation Analytical.
Articles by F.C. Girard
Advertisement
Latest Updated Articles
Nuclear Magnetic Resonance as a Bioprocessing QbD ApplicationPublished: November 1st 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
